Uptake of COVID-19 vaccine boosters has stalled in the US at less than 20% of the eligible population. Most commonly reported reason was prior SARS-CoV-2 infection (39.5%), concern about vaccine side effects (31.5%), and believing the booster would not provide additional protection (28.6%).